Deepen your insight into the #pharma and #biopharma field! 💊 Are you passionate about the (bio)pharmaceutical industry? Do you want to stay up-to-date with the latest topics, trends, and technologies driving the industry forward? 🧪 Sign up for The Medicine Maker's newsletter today: https://bit.ly/3Vu15lw Join our community of industry professionals and enthusiasts now! #PharmaceuticalIndustry #Biotechnology
About us
The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond.
- Website
-
http://themedicinemaker.com/
External link for The Medicine Maker
- Industry
- Internet Publishing
- Company size
- 11-50 employees
- Headquarters
- Knutsford, England
- Type
- Public Company
- Founded
- 2014
- Specialties
- pharmaceutical , biopharmaceutical, bioprocess, upstream, downstream, formulation, drug delivery, and dosage form
Locations
-
Primary
Get directions
Chelford Road
Knutsford, England WA16 8, GB
-
Get directions
Texere Publishing Inc. 175 Varick Street
New York, New York NY 10014, US
Updates
-
The next decade in pharma: Digitalization will accelerate processes, and sustainability will drive long-term change. Read expert opinions on how these forces will shape the industry. #PharmaFuture #InnovationInPharma https://ow.ly/jYGY50U2ifc
-
-
Digitalization has created pathways for connection and data sharing – whether for retailers, supply chain operators, or life sciences researchers – which has led to fundamental changes in the way that businesses provide value. Read on 👉🔗 https://ow.ly/27pF50UrAhp #InnovationInBusiness #SupplyChain
-
📢 On-Demand Webinar: Driving Digital Transformation in Biopharma Learn how digital transformation and close collaboration with suppliers can streamline processes, optimize decision-making, and drive productivity across development, manufacturing, and supply chain operations. Discover how the Emprove® Program and eMERGE™ Program provide easy access to essential data, enabling manufacturers to: ✅ Make informed decisions faster ✅ Improve process integration and compliance ✅ Accelerate digital maturation through collaboration and innovation 🎥 Watch the webinar on demand now! https://ow.ly/VrpR50UsAoS #Biopharma #Biopharmaceuticals #BiopharmaSupplyChain #DigitalTransformation
-
-
What lies in the pharma industry’s future? 🔮 We asked over 100 industry experts to share their views on the therapeutic areas to watch. Find out their thoughts 👉 https://ow.ly/eFJr50UsmTH #PharmaceuticalInnovation #FutureofPharma
-
-
From codon optimization to #mRNA design; explore how lessons from protein expression optimization are shaping the future of RNA-based therapies. Read the article from ATUM 👇 https://ow.ly/rQzR50TWbF3 #mRNA #CodonOptimization #PharmaInnovation
-
-
It's the last issue of the year... Welcome to the December Issue of The Medicine Maker! 📰 Check out the Innovation Awards, which showcase new drug development and manufacturing technologies launched during 2024. 🏆 Also in the issue, the past, present, and future of CRISPR-Cas9, enhancing vaccine formulations with gelatin, and an interview with Lars Erwig, Director of the Centre of Drug Development at Cancer Research UK (CRUK). 📩 Download your free digital copy here: https://ow.ly/2XTt50UtYmu 📰 Register here to receive physical copies of each issue: https://ow.ly/waPw50UtYmo #TheMedicineMaker #Biotech #PharmaIndustry #DrugDevelopment
-
83% of life science professionals are now using generative AI in their research, but concerns about the impact of disparate AI regulations remain... Find out more 🧐 https://ow.ly/1HnE50UsEzQ #GenerativeAI #LifeSciences #ResearchInnovation #AIDevelopment #BiotechResearch
AI and the Copyright Question for R&D
themedicinemaker.com
-
Welcome to our annual celebration of the top development and manufacturing technologies released over the course of the year! Check them out here 🔗 https://ow.ly/tAtS50UotJE #pharma #biopharma
-
-
The #WHO called for an effective maternal GBS vaccine that could protect infants through transplacental transfer of maternal #antibodies. Bjørn Kantsø, CTO and head of CMC, Minervax ApS answered. 🔗 https://ow.ly/JKmH50TZqeG
-